Stockholm - Delayed Quote SEK

Alteco Medical AB (ALTE.ST)

Compare
0.2280 +0.0300 (+15.15%)
At close: December 20 at 4:54:06 PM GMT+1
Loading Chart for ALTE.ST
DELL
  • Previous Close 0.1980
  • Open 0.1980
  • Bid 0.1970 x --
  • Ask 0.2280 x --
  • Day's Range 0.1960 - 0.2280
  • 52 Week Range 0.0890 - 0.4500
  • Volume 138,825
  • Avg. Volume 71,915
  • Market Cap (intraday) 13.039M
  • Beta (5Y Monthly) 0.20
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0800
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Alteco Medical AB, a medical device company, provides technology for blood purification during extracorporeal treatment. Its product portfolio includes Alteco LPS Adsorber, which removes endotoxin from the bloodstream. Alteco Medical AB was founded in 2002 and is based in Lund, Sweden.

www.altecomedical.com

4

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ALTE.ST

View More

Performance Overview: ALTE.ST

Trailing total returns as of 12/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ALTE.ST
34.86%
OMX Stockholm 30 Index
3.19%

1-Year Return

ALTE.ST
45.45%
OMX Stockholm 30 Index
3.78%

3-Year Return

ALTE.ST
76.97%
OMX Stockholm 30 Index
7.32%

5-Year Return

ALTE.ST
70.69%
OMX Stockholm 30 Index
38.77%

Compare To: ALTE.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ALTE.ST

View More

Valuation Measures

Annual
As of 12/20/2024
  • Market Cap

    13.04M

  • Enterprise Value

    12.65M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.21

  • Price/Book (mrq)

    2.43

  • Enterprise Value/Revenue

    4.30

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -209.58%

  • Return on Assets (ttm)

    -48.34%

  • Return on Equity (ttm)

    -439.99%

  • Revenue (ttm)

    3.41M

  • Net Income Avi to Common (ttm)

    -7.14M

  • Diluted EPS (ttm)

    -0.0800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    200.83k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -5.3M

Research Analysis: ALTE.ST

View More

Company Insights: ALTE.ST

Research Reports: ALTE.ST

View More

People Also Watch